Drug Regulation & QMS – Late April 2020, Turku

Regulatory requirements and quality issues are important already in the beginning of drug related research and during the R&D stage. The workshop deals with early-stage drug development aspects by Fimea, GLP and GCP principles by Heikki Niskanen from Biocad Oy and ends with 1-on-1 meetings with the experts.